Global Monogenic Disease Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Monogenic Disease Testing market size was valued at US$ 107 million in 2024 and is forecast to a readjusted size of USD 168 million by 2031 with a CAGR of 6.7% during review period.
This report is a detailed and comprehensive analysis for global Monogenic Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monogenic Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monogenic Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monogenic Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Monogenic Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monogenic Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monogenic Disease Testing, with revenue, gross margin, and global market share of Monogenic Disease Testing from 2020 to 2025.
Chapter 3, the Monogenic Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Monogenic Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Monogenic Disease Testing.
Chapter 13, to describe Monogenic Disease Testing research findings and conclusion.
This report is a detailed and comprehensive analysis for global Monogenic Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monogenic Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Monogenic Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monogenic Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monogenic Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Monogenic Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Carrier Testing
- Diagnostic Testing
- New-Born Screening
- Predictive and Pre-Symptomatic Testing
- Prenatal Testing
- Hospitals
- Clinics
- Others
- Celera Support Services
- Abbott
- ELITech Group
- Auto Genomics
- PerkinElmer
- Bio-Rad Laboratories
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monogenic Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monogenic Disease Testing, with revenue, gross margin, and global market share of Monogenic Disease Testing from 2020 to 2025.
Chapter 3, the Monogenic Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Monogenic Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Monogenic Disease Testing.
Chapter 13, to describe Monogenic Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monogenic Disease Testing by Type
1.3.1 Overview: Global Monogenic Disease Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Monogenic Disease Testing Consumption Value Market Share by Type in 2024
1.3.3 Carrier Testing
1.3.4 Diagnostic Testing
1.3.5 New-Born Screening
1.3.6 Predictive and Pre-Symptomatic Testing
1.3.7 Prenatal Testing
1.4 Global Monogenic Disease Testing Market by Application
1.4.1 Overview: Global Monogenic Disease Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Monogenic Disease Testing Market Size & Forecast
1.6 Global Monogenic Disease Testing Market Size and Forecast by Region
1.6.1 Global Monogenic Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Monogenic Disease Testing Market Size by Region, (2020-2031)
1.6.3 North America Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.6 South America Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Monogenic Disease Testing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Celera Support Services
2.1.1 Celera Support Services Details
2.1.2 Celera Support Services Major Business
2.1.3 Celera Support Services Monogenic Disease Testing Product and Solutions
2.1.4 Celera Support Services Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Celera Support Services Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Monogenic Disease Testing Product and Solutions
2.2.4 Abbott Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Abbott Recent Developments and Future Plans
2.3 ELITech Group
2.3.1 ELITech Group Details
2.3.2 ELITech Group Major Business
2.3.3 ELITech Group Monogenic Disease Testing Product and Solutions
2.3.4 ELITech Group Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 ELITech Group Recent Developments and Future Plans
2.4 Auto Genomics
2.4.1 Auto Genomics Details
2.4.2 Auto Genomics Major Business
2.4.3 Auto Genomics Monogenic Disease Testing Product and Solutions
2.4.4 Auto Genomics Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Auto Genomics Recent Developments and Future Plans
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business
2.5.3 PerkinElmer Monogenic Disease Testing Product and Solutions
2.5.4 PerkinElmer Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 PerkinElmer Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Monogenic Disease Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Monogenic Disease Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Monogenic Disease Testing by Company Revenue
3.2.2 Top 3 Monogenic Disease Testing Players Market Share in 2024
3.2.3 Top 6 Monogenic Disease Testing Players Market Share in 2024
3.3 Monogenic Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Monogenic Disease Testing Market: Region Footprint
3.3.2 Monogenic Disease Testing Market: Company Product Type Footprint
3.3.3 Monogenic Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Monogenic Disease Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Monogenic Disease Testing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Monogenic Disease Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Monogenic Disease Testing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Monogenic Disease Testing Consumption Value by Type (2020-2031)
6.2 North America Monogenic Disease Testing Market Size by Application (2020-2031)
6.3 North America Monogenic Disease Testing Market Size by Country
6.3.1 North America Monogenic Disease Testing Consumption Value by Country (2020-2031)
6.3.2 United States Monogenic Disease Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Monogenic Disease Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Monogenic Disease Testing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Monogenic Disease Testing Consumption Value by Type (2020-2031)
7.2 Europe Monogenic Disease Testing Consumption Value by Application (2020-2031)
7.3 Europe Monogenic Disease Testing Market Size by Country
7.3.1 Europe Monogenic Disease Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.3 France Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Monogenic Disease Testing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Monogenic Disease Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Monogenic Disease Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Monogenic Disease Testing Market Size by Region
8.3.1 Asia-Pacific Monogenic Disease Testing Consumption Value by Region (2020-2031)
8.3.2 China Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.5 India Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Monogenic Disease Testing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Monogenic Disease Testing Consumption Value by Type (2020-2031)
9.2 South America Monogenic Disease Testing Consumption Value by Application (2020-2031)
9.3 South America Monogenic Disease Testing Market Size by Country
9.3.1 South America Monogenic Disease Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Monogenic Disease Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Monogenic Disease Testing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Monogenic Disease Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Monogenic Disease Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Monogenic Disease Testing Market Size by Country
10.3.1 Middle East & Africa Monogenic Disease Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Monogenic Disease Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Monogenic Disease Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Monogenic Disease Testing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Monogenic Disease Testing Market Drivers
11.2 Monogenic Disease Testing Market Restraints
11.3 Monogenic Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Monogenic Disease Testing Industry Chain
12.2 Monogenic Disease Testing Upstream Analysis
12.3 Monogenic Disease Testing Midstream Analysis
12.4 Monogenic Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Monogenic DiseaseTesting Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Monogenic DiseaseTesting Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Monogenic DiseaseTesting Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Monogenic DiseaseTesting Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Celera Support Services Company Information, Head Office, and Major Competitors
Table 6. Celera Support Services Major Business
Table 7. Celera Support Services Monogenic DiseaseTesting Product and Solutions
Table 8. Celera Support Services Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Celera Support Services Recent Developments andFuture Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Monogenic DiseaseTesting Product and Solutions
Table 13. Abbott Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Abbott Recent Developments andFuture Plans
Table 15. ELITech Group Company Information, Head Office, and Major Competitors
Table 16. ELITech Group Major Business
Table 17. ELITech Group Monogenic DiseaseTesting Product and Solutions
Table 18. ELITech Group Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Auto Genomics Company Information, Head Office, and Major Competitors
Table 20. Auto Genomics Major Business
Table 21. Auto Genomics Monogenic DiseaseTesting Product and Solutions
Table 22. Auto Genomics Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Auto Genomics Recent Developments andFuture Plans
Table 24. PerkinElmer Company Information, Head Office, and Major Competitors
Table 25. PerkinElmer Major Business
Table 26. PerkinElmer Monogenic DiseaseTesting Product and Solutions
Table 27. PerkinElmer Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. PerkinElmer Recent Developments andFuture Plans
Table 29. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad Laboratories Major Business
Table 31. Bio-Rad Laboratories Monogenic DiseaseTesting Product and Solutions
Table 32. Bio-Rad Laboratories Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bio-Rad Laboratories Recent Developments andFuture Plans
Table 34. Global Monogenic DiseaseTesting Revenue (USD Million) by Players (2020-2025)
Table 35. Global Monogenic DiseaseTesting Revenue Share by Players (2020-2025)
Table 36. Breakdown of Monogenic DiseaseTesting by CompanyType (Tier 1,Tier 2, andTier 3)
Table 37. Market Position of Players in Monogenic DiseaseTesting, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 38. Head Office of Key Monogenic DiseaseTesting Players
Table 39. Monogenic DiseaseTesting Market: Company ProductTypeFootprint
Table 40. Monogenic DiseaseTesting Market: Company Product ApplicationFootprint
Table 41. Monogenic DiseaseTesting New Market Entrants and Barriers to Market Entry
Table 42. Monogenic DiseaseTesting Mergers, Acquisition, Agreements, and Collaborations
Table 43. Global Monogenic DiseaseTesting Consumption Value (USD Million) byType (2020-2025)
Table 44. Global Monogenic DiseaseTesting Consumption Value Share byType (2020-2025)
Table 45. Global Monogenic DiseaseTesting Consumption ValueForecast byType (2026-2031)
Table 46. Global Monogenic DiseaseTesting Consumption Value by Application (2020-2025)
Table 47. Global Monogenic DiseaseTesting Consumption ValueForecast by Application (2026-2031)
Table 48. North America Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 49. North America Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 50. North America Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 51. North America Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 52. North America Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 53. North America Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 54. Europe Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 55. Europe Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 56. Europe Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 57. Europe Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 58. Europe Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 59. Europe Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 60. Asia-Pacific Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 61. Asia-Pacific Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 62. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 63. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 64. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Region (2020-2025) & (USD Million)
Table 65. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Region (2026-2031) & (USD Million)
Table 66. South America Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 67. South America Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 68. South America Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 69. South America Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 70. South America Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 71. South America Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 72. Middle East & Africa Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 73. Middle East & Africa Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 74. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 75. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 76. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 77. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 78. Global Key Players of Monogenic DiseaseTesting Upstream (Raw Materials)
Table 79. Global Monogenic DiseaseTestingTypical Customers
LIST OFFIGURES
Figure 1. Monogenic DiseaseTesting Picture
Figure 2. Global Monogenic DiseaseTesting Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Monogenic DiseaseTesting Consumption Value Market Share byType in 2024
Figure 4. CarrierTesting
Figure 5. DiagnosticTesting
Figure 6. New-Born Screening
Figure 7. Predictive and Pre-SymptomaticTesting
Figure 8. PrenatalTesting
Figure 9. Global Monogenic DiseaseTesting Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Monogenic DiseaseTesting Consumption Value Market Share by Application in 2024
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Others Picture
Figure 14. Global Monogenic DiseaseTesting Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Monogenic DiseaseTesting Consumption Value andForecast (2020-2031) & (USD Million)
Figure 16. Global Market Monogenic DiseaseTesting Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Monogenic DiseaseTesting Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Monogenic DiseaseTesting Consumption Value Market Share by Region in 2024
Figure 19. North America Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 24. CompanyThree Recent Developments andFuture Plans
Figure 25. Global Monogenic DiseaseTesting Revenue Share by Players in 2024
Figure 26. Monogenic DiseaseTesting Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 27. Market Share of Monogenic DiseaseTesting by Player Revenue in 2024
Figure 28.Top 3 Monogenic DiseaseTesting Players Market Share in 2024
Figure 29.Top 6 Monogenic DiseaseTesting Players Market Share in 2024
Figure 30. Global Monogenic DiseaseTesting Consumption Value Share byType (2020-2025)
Figure 31. Global Monogenic DiseaseTesting Market ShareForecast byType (2026-2031)
Figure 32. Global Monogenic DiseaseTesting Consumption Value Share by Application (2020-2025)
Figure 33. Global Monogenic DiseaseTesting Market ShareForecast by Application (2026-2031)
Figure 34. North America Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 35. North America Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 41. Europe Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 44.France Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 49. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share by Region (2020-2031)
Figure 51. China Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 54. India Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 58. South America Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 63. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 65.Turkey Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 68. Monogenic DiseaseTesting Market Drivers
Figure 69. Monogenic DiseaseTesting Market Restraints
Figure 70. Monogenic DiseaseTesting MarketTrends
Figure 71. PortersFiveForces Analysis
Figure 72. Monogenic DiseaseTesting Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monogenic Disease Testing by Type
1.3.1 Overview: Global Monogenic Disease Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Monogenic Disease Testing Consumption Value Market Share by Type in 2024
1.3.3 Carrier Testing
1.3.4 Diagnostic Testing
1.3.5 New-Born Screening
1.3.6 Predictive and Pre-Symptomatic Testing
1.3.7 Prenatal Testing
1.4 Global Monogenic Disease Testing Market by Application
1.4.1 Overview: Global Monogenic Disease Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Monogenic Disease Testing Market Size & Forecast
1.6 Global Monogenic Disease Testing Market Size and Forecast by Region
1.6.1 Global Monogenic Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Monogenic Disease Testing Market Size by Region, (2020-2031)
1.6.3 North America Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.6 South America Monogenic Disease Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Monogenic Disease Testing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Celera Support Services
2.1.1 Celera Support Services Details
2.1.2 Celera Support Services Major Business
2.1.3 Celera Support Services Monogenic Disease Testing Product and Solutions
2.1.4 Celera Support Services Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Celera Support Services Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Monogenic Disease Testing Product and Solutions
2.2.4 Abbott Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Abbott Recent Developments and Future Plans
2.3 ELITech Group
2.3.1 ELITech Group Details
2.3.2 ELITech Group Major Business
2.3.3 ELITech Group Monogenic Disease Testing Product and Solutions
2.3.4 ELITech Group Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 ELITech Group Recent Developments and Future Plans
2.4 Auto Genomics
2.4.1 Auto Genomics Details
2.4.2 Auto Genomics Major Business
2.4.3 Auto Genomics Monogenic Disease Testing Product and Solutions
2.4.4 Auto Genomics Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Auto Genomics Recent Developments and Future Plans
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business
2.5.3 PerkinElmer Monogenic Disease Testing Product and Solutions
2.5.4 PerkinElmer Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 PerkinElmer Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Monogenic Disease Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Monogenic Disease Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Monogenic Disease Testing by Company Revenue
3.2.2 Top 3 Monogenic Disease Testing Players Market Share in 2024
3.2.3 Top 6 Monogenic Disease Testing Players Market Share in 2024
3.3 Monogenic Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Monogenic Disease Testing Market: Region Footprint
3.3.2 Monogenic Disease Testing Market: Company Product Type Footprint
3.3.3 Monogenic Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Monogenic Disease Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Monogenic Disease Testing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Monogenic Disease Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Monogenic Disease Testing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Monogenic Disease Testing Consumption Value by Type (2020-2031)
6.2 North America Monogenic Disease Testing Market Size by Application (2020-2031)
6.3 North America Monogenic Disease Testing Market Size by Country
6.3.1 North America Monogenic Disease Testing Consumption Value by Country (2020-2031)
6.3.2 United States Monogenic Disease Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Monogenic Disease Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Monogenic Disease Testing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Monogenic Disease Testing Consumption Value by Type (2020-2031)
7.2 Europe Monogenic Disease Testing Consumption Value by Application (2020-2031)
7.3 Europe Monogenic Disease Testing Market Size by Country
7.3.1 Europe Monogenic Disease Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.3 France Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Monogenic Disease Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Monogenic Disease Testing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Monogenic Disease Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Monogenic Disease Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Monogenic Disease Testing Market Size by Region
8.3.1 Asia-Pacific Monogenic Disease Testing Consumption Value by Region (2020-2031)
8.3.2 China Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.5 India Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Monogenic Disease Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Monogenic Disease Testing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Monogenic Disease Testing Consumption Value by Type (2020-2031)
9.2 South America Monogenic Disease Testing Consumption Value by Application (2020-2031)
9.3 South America Monogenic Disease Testing Market Size by Country
9.3.1 South America Monogenic Disease Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Monogenic Disease Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Monogenic Disease Testing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Monogenic Disease Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Monogenic Disease Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Monogenic Disease Testing Market Size by Country
10.3.1 Middle East & Africa Monogenic Disease Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Monogenic Disease Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Monogenic Disease Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Monogenic Disease Testing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Monogenic Disease Testing Market Drivers
11.2 Monogenic Disease Testing Market Restraints
11.3 Monogenic Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Monogenic Disease Testing Industry Chain
12.2 Monogenic Disease Testing Upstream Analysis
12.3 Monogenic Disease Testing Midstream Analysis
12.4 Monogenic Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Monogenic DiseaseTesting Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Monogenic DiseaseTesting Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Monogenic DiseaseTesting Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Monogenic DiseaseTesting Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Celera Support Services Company Information, Head Office, and Major Competitors
Table 6. Celera Support Services Major Business
Table 7. Celera Support Services Monogenic DiseaseTesting Product and Solutions
Table 8. Celera Support Services Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Celera Support Services Recent Developments andFuture Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Monogenic DiseaseTesting Product and Solutions
Table 13. Abbott Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Abbott Recent Developments andFuture Plans
Table 15. ELITech Group Company Information, Head Office, and Major Competitors
Table 16. ELITech Group Major Business
Table 17. ELITech Group Monogenic DiseaseTesting Product and Solutions
Table 18. ELITech Group Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Auto Genomics Company Information, Head Office, and Major Competitors
Table 20. Auto Genomics Major Business
Table 21. Auto Genomics Monogenic DiseaseTesting Product and Solutions
Table 22. Auto Genomics Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Auto Genomics Recent Developments andFuture Plans
Table 24. PerkinElmer Company Information, Head Office, and Major Competitors
Table 25. PerkinElmer Major Business
Table 26. PerkinElmer Monogenic DiseaseTesting Product and Solutions
Table 27. PerkinElmer Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. PerkinElmer Recent Developments andFuture Plans
Table 29. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad Laboratories Major Business
Table 31. Bio-Rad Laboratories Monogenic DiseaseTesting Product and Solutions
Table 32. Bio-Rad Laboratories Monogenic DiseaseTesting Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bio-Rad Laboratories Recent Developments andFuture Plans
Table 34. Global Monogenic DiseaseTesting Revenue (USD Million) by Players (2020-2025)
Table 35. Global Monogenic DiseaseTesting Revenue Share by Players (2020-2025)
Table 36. Breakdown of Monogenic DiseaseTesting by CompanyType (Tier 1,Tier 2, andTier 3)
Table 37. Market Position of Players in Monogenic DiseaseTesting, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 38. Head Office of Key Monogenic DiseaseTesting Players
Table 39. Monogenic DiseaseTesting Market: Company ProductTypeFootprint
Table 40. Monogenic DiseaseTesting Market: Company Product ApplicationFootprint
Table 41. Monogenic DiseaseTesting New Market Entrants and Barriers to Market Entry
Table 42. Monogenic DiseaseTesting Mergers, Acquisition, Agreements, and Collaborations
Table 43. Global Monogenic DiseaseTesting Consumption Value (USD Million) byType (2020-2025)
Table 44. Global Monogenic DiseaseTesting Consumption Value Share byType (2020-2025)
Table 45. Global Monogenic DiseaseTesting Consumption ValueForecast byType (2026-2031)
Table 46. Global Monogenic DiseaseTesting Consumption Value by Application (2020-2025)
Table 47. Global Monogenic DiseaseTesting Consumption ValueForecast by Application (2026-2031)
Table 48. North America Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 49. North America Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 50. North America Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 51. North America Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 52. North America Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 53. North America Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 54. Europe Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 55. Europe Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 56. Europe Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 57. Europe Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 58. Europe Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 59. Europe Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 60. Asia-Pacific Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 61. Asia-Pacific Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 62. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 63. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 64. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Region (2020-2025) & (USD Million)
Table 65. Asia-Pacific Monogenic DiseaseTesting Consumption Value by Region (2026-2031) & (USD Million)
Table 66. South America Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 67. South America Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 68. South America Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 69. South America Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 70. South America Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 71. South America Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 72. Middle East & Africa Monogenic DiseaseTesting Consumption Value byType (2020-2025) & (USD Million)
Table 73. Middle East & Africa Monogenic DiseaseTesting Consumption Value byType (2026-2031) & (USD Million)
Table 74. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Application (2020-2025) & (USD Million)
Table 75. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Application (2026-2031) & (USD Million)
Table 76. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Country (2020-2025) & (USD Million)
Table 77. Middle East & Africa Monogenic DiseaseTesting Consumption Value by Country (2026-2031) & (USD Million)
Table 78. Global Key Players of Monogenic DiseaseTesting Upstream (Raw Materials)
Table 79. Global Monogenic DiseaseTestingTypical Customers
LIST OFFIGURES
Figure 1. Monogenic DiseaseTesting Picture
Figure 2. Global Monogenic DiseaseTesting Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Monogenic DiseaseTesting Consumption Value Market Share byType in 2024
Figure 4. CarrierTesting
Figure 5. DiagnosticTesting
Figure 6. New-Born Screening
Figure 7. Predictive and Pre-SymptomaticTesting
Figure 8. PrenatalTesting
Figure 9. Global Monogenic DiseaseTesting Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Monogenic DiseaseTesting Consumption Value Market Share by Application in 2024
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Others Picture
Figure 14. Global Monogenic DiseaseTesting Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Monogenic DiseaseTesting Consumption Value andForecast (2020-2031) & (USD Million)
Figure 16. Global Market Monogenic DiseaseTesting Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Monogenic DiseaseTesting Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Monogenic DiseaseTesting Consumption Value Market Share by Region in 2024
Figure 19. North America Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 24. CompanyThree Recent Developments andFuture Plans
Figure 25. Global Monogenic DiseaseTesting Revenue Share by Players in 2024
Figure 26. Monogenic DiseaseTesting Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 27. Market Share of Monogenic DiseaseTesting by Player Revenue in 2024
Figure 28.Top 3 Monogenic DiseaseTesting Players Market Share in 2024
Figure 29.Top 6 Monogenic DiseaseTesting Players Market Share in 2024
Figure 30. Global Monogenic DiseaseTesting Consumption Value Share byType (2020-2025)
Figure 31. Global Monogenic DiseaseTesting Market ShareForecast byType (2026-2031)
Figure 32. Global Monogenic DiseaseTesting Consumption Value Share by Application (2020-2025)
Figure 33. Global Monogenic DiseaseTesting Market ShareForecast by Application (2026-2031)
Figure 34. North America Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 35. North America Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 41. Europe Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 44.France Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 49. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Monogenic DiseaseTesting Consumption Value Market Share by Region (2020-2031)
Figure 51. China Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 54. India Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 58. South America Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share byType (2020-2031)
Figure 63. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Monogenic DiseaseTesting Consumption Value Market Share by Country (2020-2031)
Figure 65.Turkey Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Monogenic DiseaseTesting Consumption Value (2020-2031) & (USD Million)
Figure 68. Monogenic DiseaseTesting Market Drivers
Figure 69. Monogenic DiseaseTesting Market Restraints
Figure 70. Monogenic DiseaseTesting MarketTrends
Figure 71. PortersFiveForces Analysis
Figure 72. Monogenic DiseaseTesting Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
More Publications
Global Soft Strain Sensors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
September 2025
78 pages
Global Generative Design Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
September 2026
111 pages
Global Common Mode Inductor Filters Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
US$ 3,480.00
February 2023
119 pages
Global E-sports Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
July 2024
115 pages
Global Small Business Phone Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
March 2025
133 pages
